Literature DB >> 11562915

Kell and XK immunohistochemistry in McLeod myopathy.

H H Jung1, D Russo, C Redman, S Brandner.   

Abstract

The McLeod syndrome is an X-linked neuroacanthocytosis manifesting with myopathy and progressive chorea. It is caused by mutations of the XK gene encoding the XK protein, a putative membrane transport protein of yet unknown function. In erythroid tissues, XK forms a functional complex with the Kell glycoprotein. Here, we present an immunohistochemical study in skeletal muscle of normal controls and a McLeod patient with a XK gene point mutation (C977T) using affinity-purified antibodies against XK and Kell proteins. Histological examination of the affected muscle revealed the typical pattern of McLeod myopathy including type 2 fiber atrophy. In control muscles, Kell immunohistochemistry stained sarcoplasmic membranes. XK immunohistochemistry resulted in a type 2 fiber-specific intracellular staining that was most probably confined to the sarcoplasmic reticulum. In contrast, there was only a weak background signal without a specific staining pattern for XK and Kell in the McLeod muscle. Our results demonstrate that the lack of physiological XK expression correlates to the type 2 fiber atrophy in McLeod myopathy, and suggest that the XK protein represents a crucial factor for the maintenance of normal muscle structure and function. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562915     DOI: 10.1002/mus.1154

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

1.  Giant axon formation in mice lacking Kell, XK, or Kell and XK: animal models of McLeod neuroacanthocytosis syndrome.

Authors:  Xiang Zhu; Eun-Sook Cho; Quan Sha; Jianbin Peng; Yelena Oksov; Siok Yuen Kam; Mengfatt Ho; Ruth H Walker; Soohee Lee
Journal:  Am J Pathol       Date:  2014-01-07       Impact factor: 4.307

Review 2.  XK-Associated McLeod Syndrome: Nonhematological Manifestations and Relation to VPS13A Disease.

Authors:  Kevin Peikert; Andreas Hermann; Adrian Danek
Journal:  Transfus Med Hemother       Date:  2022-01-25       Impact factor: 3.747

Review 3.  Movement disorders and neuropathies: overlaps and mimics in clinical practice.

Authors:  Francesco Gentile; Alessandro Bertini; Alberto Priori; Tommaso Bocci
Journal:  J Neurol       Date:  2022-06-03       Impact factor: 6.682

4.  Ablation of the Kell/Xk complex alters erythrocyte divalent cation homeostasis.

Authors:  Alicia Rivera; Siok Yuen Kam; Mengfatt Ho; Jose R Romero; Soohee Lee
Journal:  Blood Cells Mol Dis       Date:  2012-10-31       Impact factor: 3.039

5.  Neuroacanthocytosis Syndromes in an Italian Cohort: Clinical Spectrum, High Genetic Variability and Muscle Involvement.

Authors:  Alessandro Vaisfeld; Giorgia Bruno; Martina Petracca; Anna Rita Bentivoglio; Serenella Servidei; Maria Gabriella Vita; Francesco Bove; Giulia Straccia; Clemente Dato; Giuseppe Di Iorio; Simone Sampaolo; Silvio Peluso; Anna De Rosa; Giuseppe De Michele; Melissa Barghigiani; Daniele Galatolo; Alessandra Tessa; Filippo Santorelli; Pietro Chiurazzi; Mariarosa Anna Beatrice Melone
Journal:  Genes (Basel)       Date:  2021-02-26       Impact factor: 4.096

Review 6.  Neuroacanthocytosis syndromes.

Authors:  Hans H Jung; Adrian Danek; Ruth H Walker
Journal:  Orphanet J Rare Dis       Date:  2011-10-25       Impact factor: 4.123

Review 7.  Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes.

Authors:  Ruth H Walker
Journal:  J Mov Disord       Date:  2015-05-31

8.  Clinical and molecular research of neuroacanthocytosis.

Authors:  Lihong Zhang; Suping Wang; Jianwen Lin
Journal:  Neural Regen Res       Date:  2013-03-25       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.